Swedbank AB Purchases 2,206 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Swedbank AB grew its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 132,603 shares of the biotechnology company’s stock after buying an additional 2,206 shares during the period. Swedbank AB owned 0.18% of Axon Enterprise worth $52,988,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Blue Trust Inc. lifted its stake in shares of Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after buying an additional 79 shares in the last quarter. Quent Capital LLC lifted its position in Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after acquiring an additional 75 shares in the last quarter. Asset Dedication LLC purchased a new stake in Axon Enterprise during the 2nd quarter valued at $47,000. Planning Capital Management Corp boosted its stake in Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares during the last quarter. Finally, Friedenthal Financial bought a new stake in shares of Axon Enterprise in the 3rd quarter worth $51,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Stock Up 0.9 %

Shares of AXON stock opened at $636.95 on Monday. The company has a market capitalization of $48.57 billion, a price-to-earnings ratio of 164.59, a PEG ratio of 14.02 and a beta of 0.94. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company’s fifty day moving average price is $463.58 and its 200-day moving average price is $368.47. Axon Enterprise, Inc. has a one year low of $224.28 and a one year high of $641.20.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Robert W. Baird increased their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. JMP Securities lifted their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. The Goldman Sachs Group increased their price target on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Finally, Barclays lifted their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $427.83.

Insider Buying and Selling at Axon Enterprise

In related news, CEO Patrick W. Smith sold 50,000 shares of the stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $364.02, for a total transaction of $18,201,000.00. Following the completion of the sale, the chief executive officer now owns 2,980,861 shares in the company, valued at approximately $1,085,093,021.22. This trade represents a 1.65 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, President Joshua Isner sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the transaction, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 260,256 shares of company stock valued at $105,984,120 over the last ninety days. 5.70% of the stock is currently owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.